Innate Pharma
IPHA
#8351
Rank
C$0.23 B
Marketcap
$2.74
Share price
0.00%
Change (1 day)
-18.49%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -C$11.6 Million

According to Innate Pharma 's latest financial reports the company's current earnings are C$57.37 Million. In 2023 the company made an earning of -C$11.6 Million, an increase over its 2022 earnings that were of -C$86.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-C$11.6 Million-86.54%
2022-C$86.16 Million20.74%
2021-C$71.36 Million4951.09%
2020-C$1.42 Million-111.57%
2019C$12.21 M183.46%
2018C$4.3 M-105.4%
2017-C$79.82 Million-523.25%
2016C$18.85 M-285.64%
2015-C$10.16 Million-69.31%
2014-C$33.11 Million498.29%
2013-C$5.54 Million-5.62%
2012-C$5.87 Million-53.32%
2011-C$12.56 Million-50.1%
2010-C$25.17 Million-13.3%
2009-C$29.04 Million26.36%
2008-C$22.98 Million27.35%
2007-C$18.04 Million63.33%
2006-C$11.05 Million9.81%
2005-C$10.06 Million